Effectiveness of Erythropoiesis-Stimulating Agent Therapy with Oral and Intravenous Iron Supplementation in Achieving Hemoglobin Targets in Stage 5 Chronic Kidney Disease Patients. JFM [Internet]. 2026 Oct. 30 [cited 2026 Nov. 1];9(1):499-507. Available from: https://ejournal.medistra.ac.id/index.php/JFM/article/view/3691